Ram P A, Waxman D J
Department of Biological Chemistry and Molecular Pharmacology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115.
Mol Endocrinol. 1991 Jan;5(1):13-20. doi: 10.1210/mend-5-1-13.
Studies carried out in hypophysectomized adult rats have demonstrated that both thyroid hormone and GH can suppress hepatic expression of the steroid 6 beta-hydroxylase P450 2a (IIIA2). The present study further characterizes the influence of thyroid hormone on the expression of P450 2a and two other male-specific hepatic P450s, a steroid 2 alpha/16 alpha-hydroxylase, designated P450 2c (IIC11), and a steroid 15 alpha-hydroxylase, designated P450 RLM2 (IIA2). These studies were carried out in rats rendered hypothyroid by treatment with methimazole, which allows for the nonsurgical depletion of circulating T4, and in hypophysectomized rats. Hypothyroidism led to an increase in hepatic P450 2a (IIIA2) protein and mRNA in both male and female rats that was fully reversed by T4 replacement. In contrast, hypothyroidism decreased by 70-80% the expression of P450 2c (IIC11) activity and mRNA, but did not significantly alter the expression of P450 RLM2 (IIA2). The decrease in P450 2c (IIC11) was not reversed by T4 replacement, suggesting that it is a consequence of the loss of plasma GH pulses that occurs secondary to hypothyroidism. In agreement with these findings, T4 given to hypophysectomized rats partially suppressed the expression of P450 2a (IIIA2) mRNA, but not P450 2c (IIC11) or P450 RLM2 (IIA2) mRNA. A more complete suppression of P450 2a (IIIA2) mRNA as well as P450 2c (IIC11) mRNA was achieved when the hypophysectomized rats were treated with T3 at a supraphysiological, receptor-saturating dose. Although GH administered to intact male rats by continuous infusion fully suppressed all three male-specific P450 proteins and their mRNAs, the same treatment given to hypothyroid rats was only partially suppressive in the case of P450 2a (IIIA2) and P450 RLM2 (IIA2), unless combined with T4. In the case of P450 2c (IIC11), substantial suppression of the residual P450 present in hypothyroid rats was achieved by treatment with GH alone, despite persistent thyroid hormone deficiency. These studies demonstrate that while thyroid hormone is a negative regulator of P450 2a (IIIA2) expression and is required for the full suppression of that P450 and P450 RLM2 (IIA2) by the continuous plasma GH profiles associated with adult female rats, the suppression of P450 2c (IIC11) by continuous plasma GH is largely independent of the presence of thyroid hormone.
在切除垂体的成年大鼠身上进行的研究表明,甲状腺激素和生长激素(GH)均可抑制类固醇6β-羟化酶P450 2a(IIIA2)的肝脏表达。本研究进一步阐明了甲状腺激素对P450 2a以及另外两种雄性特异性肝脏P450的表达的影响,这两种酶分别是类固醇2α/16α-羟化酶,命名为P450 2c(IIC11),以及类固醇15α-羟化酶,命名为P450 RLM2(IIA2)。这些研究是在通过甲巯咪唑治疗致使甲状腺功能减退的大鼠(该方法可在不进行手术的情况下使循环中的T4减少)以及切除垂体的大鼠身上进行的。甲状腺功能减退导致雄性和雌性大鼠肝脏中P450 2a(IIIA2)蛋白和mRNA增加,而T4替代治疗可使其完全恢复。相比之下,甲状腺功能减退使P450 2c(IIC11)活性和mRNA的表达降低了70 - 80%,但对P450 RLM2(IIA2)的表达没有显著影响。T4替代治疗未能逆转P450 2c(IIC11)的降低,这表明它是甲状腺功能减退继发的血浆GH脉冲丧失的结果。与这些发现一致,给切除垂体的大鼠注射T4可部分抑制P�50 2a(IIIA2)mRNA的表达,但对P450 2c(IIC11)或P450 RLM2(IIA2)mRNA无抑制作用。当给切除垂体的大鼠以超生理剂量且能使受体饱和的T3进行治疗时,可更完全地抑制P450 2a(IIIA2)mRNA以及P450 2c(IIC11)mRNA的表达。尽管通过持续输注向完整雄性大鼠注射GH可完全抑制所有三种雄性特异性P450蛋白及其mRNA的表达,但对于甲状腺功能减退的大鼠,同样的治疗仅对P450 2a(IIIA2)和P450 RLM2(IIA2)有部分抑制作用,除非联合T4。对于P450 2c(IIC11),尽管持续存在甲状腺激素缺乏,但单独使用GH治疗可显著抑制甲状腺功能减退大鼠体内残留的P450的表达。这些研究表明,虽然甲状腺激素是P450 2a(IIIA2)表达的负调节因子,并且对于成年雌性大鼠相关的持续血浆GH水平对该P450和P450 RLM2(IIA2)的完全抑制是必需的,但持续血浆GH对P450 2c(IIC11)的抑制在很大程度上独立于甲状腺激素的存在。